Page last updated: 2024-09-02

fingolimod hydrochloride and Injuries, Radiation

fingolimod hydrochloride has been researched along with Injuries, Radiation in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Donoviel, DB; Jones, JA; McLaughlin, MF	1
Banu, MA; Berry, N; Boockvar, JA; Clausi, MG; Ryu, S; Stessin, AM	1
Chen, YX; Guo, L; Sun, J; Zeng, ZC; Zhang, SM	1

Reviews

1 review(s) available for fingolimod hydrochloride and Injuries, Radiation

Article	Year
Novel Indications for Commonly Used Medications as Radiation Protectants in Spaceflight. Aerospace medicine and human performance, 2017, Jul-01, Volume: 88, Issue:7 Topics: Acetylcysteine; Adrenergic beta-Antagonists; Aerospace Medicine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Astronauts; Calcium Channel Blockers; Fingolimod Hydrochloride; Free Radical Scavengers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Immunosuppressive Agents; Metformin; Pentoxifylline; Radiation Injuries; Radiation-Protective Agents; Space Flight	2017

Article

Year

Novel Indications for Commonly Used Medications as Radiation Protectants in Spaceflight.

Aerospace medicine and human performance, 2017, Jul-01, Volume: 88, Issue:7

Topics: Acetylcysteine; Adrenergic beta-Antagonists; Aerospace Medicine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Astronauts; Calcium Channel Blockers; Fingolimod Hydrochloride; Free Radical Scavengers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Immunosuppressive Agents; Metformin; Pentoxifylline; Radiation Injuries; Radiation-Protective Agents; Space Flight

2017

Other Studies

2 other study(ies) available for fingolimod hydrochloride and Injuries, Radiation

Article	Year
FTY720/fingolimod, an oral S1PR modulator, mitigates radiation induced cognitive deficits. Neuroscience letters, 2017, Sep-29, Volume: 658 Topics: Animals; Brain Neoplasms; Cognition; Cognitive Dysfunction; Fingolimod Hydrochloride; Hippocampus; Mice, Inbred C57BL; Neural Stem Cells; Neurogenesis; Radiation Injuries; Radiotherapy; Receptors, Lysosphingolipid	2017
FTY720, a sphingosine-1-phosphate (S1P) receptor modulator, protects sinusoid endothelial cells from radiation injury in vitro. Hepatology international, 2015, Volume: 9, Issue:1 Topics: Apoptosis; Cell Survival; Endothelial Cells; Fingolimod Hydrochloride; Hep G2 Cells; Humans; Liver; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Radiation Injuries; Radiation Tolerance; Radiation-Protective Agents; Receptors, Lysosphingolipid; Signal Transduction	2015

Article

Year

FTY720/fingolimod, an oral S1PR modulator, mitigates radiation induced cognitive deficits.

Neuroscience letters, 2017, Sep-29, Volume: 658

Topics: Animals; Brain Neoplasms; Cognition; Cognitive Dysfunction; Fingolimod Hydrochloride; Hippocampus; Mice, Inbred C57BL; Neural Stem Cells; Neurogenesis; Radiation Injuries; Radiotherapy; Receptors, Lysosphingolipid

2017

FTY720, a sphingosine-1-phosphate (S1P) receptor modulator, protects sinusoid endothelial cells from radiation injury in vitro.

Hepatology international, 2015, Volume: 9, Issue:1

Topics: Apoptosis; Cell Survival; Endothelial Cells; Fingolimod Hydrochloride; Hep G2 Cells; Humans; Liver; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Radiation Injuries; Radiation Tolerance; Radiation-Protective Agents; Receptors, Lysosphingolipid; Signal Transduction

2015